According to Array Technologies's latest financial reports the company has a price-to-book ratio of 3.08.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 4.16 | -39.37% |
2022-12-31 | 6.86 | -45.49% |
2021-12-31 | 12.6 | -118.59% |
2020-12-31 | -67.7 | |
2019-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Novartis NVS | 5.03 | 63.32% | ๐จ๐ญ Switzerland |
Eli Lilly LLY | 64.2 | 1,983.09% | ๐บ๐ธ USA |
Amgen AMGN | 23.2 | 654.02% | ๐บ๐ธ USA |
AstraZeneca AZN | 6.21 | 101.67% | ๐ฌ๐ง UK |
Onconova Therapeutics ONTX | 1.44 | -53.27% | ๐บ๐ธ USA |